The purpose of this study was to establish the precise mechanism by which KAI1 (CD82), a metastasis-suppressor gene initially discovered in prostate cancer, inhibits Src and affects the metastasis of prostate carcinoma. Here, CD82 is linked to Familial prostate cancer.